<code id='40C9083563'></code><style id='40C9083563'></style>
    • <acronym id='40C9083563'></acronym>
      <center id='40C9083563'><center id='40C9083563'><tfoot id='40C9083563'></tfoot></center><abbr id='40C9083563'><dir id='40C9083563'><tfoot id='40C9083563'></tfoot><noframes id='40C9083563'>

    • <optgroup id='40C9083563'><strike id='40C9083563'><sup id='40C9083563'></sup></strike><code id='40C9083563'></code></optgroup>
        1. <b id='40C9083563'><label id='40C9083563'><select id='40C9083563'><dt id='40C9083563'><span id='40C9083563'></span></dt></select></label></b><u id='40C9083563'></u>
          <i id='40C9083563'><strike id='40C9083563'><tt id='40C9083563'><pre id='40C9083563'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:2
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Roche to buy Carmot Therapeutics, developer of obesity drugs
          Roche to buy Carmot Therapeutics, developer of obesity drugs

          SebastienBozon/AFPviaGettyImagesLONDON—Theboomingobesitymarketisattractinganotherplayer,aspharmagian

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

          STEFANIREYNOLDS/AFPviaGettyImagesUnderstandhowscience,healthpolicy,andmedicineshapetheworldeveryday.